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ABSTRACT 
Background: Attention deficit hyperactive disorder (ADHD) is a common and disabling 
disorder, affecting 2-4% of the adult population worldwide. Pharmacological treatment is often 
the only available option, however medication is not sufficient for 50-70% of the adults. Thus, it 
is necessary to develop and evaluate complementary treatments. 
Although treatments such as cognitive and dialectic behavioral therapy (CBT and DBT) in the 
treatment of ADHD have been promising, they have each targeted different aspects of ADHD 
symptomatology, thus neither one has addressed the total variety of symptoms typically 
displayed in adults. Moreover, accessibility to these treatments is low.  
Aims: General aims of this thesis were to develop and evaluate the efficacy of new 
psychological interventions for adult ADHD, addressing a variety of common impairments 
associated with the diagnosis, with the intention to make these interventions accessible and 
available through internet.  
Methods: Three clinical trials were conducted. In study I, a randomized controlled trial (RCT; 
n=57), adults with ADHD or probable ADHD, with pronounced difficulties with inattention and 
organization, took part in an internet-based course on how to structure their everyday life with 
smartphone applications and online-tools and were compared to a wait-list control group. Study 
II, an uncontrolled study (n=18), evaluated the feasibility and preliminary effect of a novel 
treatment based on a combination of CBT and DBT. Study III, an RCT evaluating internet-
based treatment for adults with ADHD (n=104), explored the efficacy of the combination 
treatment (ICBT) compared to an active and credible control group (internet-based applied 
relaxation training, IART) and to treatment as usual (TAU).  
 
Results: The intervention in study I showed large effects on attention and organization skills for 
participants in the intervention group. Moreover, the improvements on hyperactivity and 
depression severity were also significantly better compared to the wait-list condition. The 
combined group treatment in study II turned out to be feasible and beneficial with large 
reductions of ADHD symptoms and related problems such as depression and experienced 
stress. Reductions in ADHD symptoms were maintained up to 6 months after treatment. In 
study III, ICBT and IART were shown to be equally effective with moderate effects on ADHD 
symptoms compared to TAU up to one year after treatment. The only significant interaction 
between both treatments over time was for level of general everyday functioning, favoring 
ICBT. Satisfaction ratings were high in the ICBT group, however some of the participants 
experienced the treatment as stressful or overwhelming.  
 
Conclusions: The smartphone course, as well as the combination treatment administered in a 
group format, seems to be feasible and effective in improving ADHD symptoms and related 
problems. The internet-based combined treatment was also effective compared to treatment as 
usual and has the potential to increase accessibility and availability to treatment. Sustained 
effects were also found for the combination treatment (studies II-III) in the long term. However, 
   
future adjustments in content need to be made to enhance the specific effects on ADHD and 
related symptoms. 
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1 INTRODUCTION 
 
“I am in the mood to dissolve the sky.” ~ Virginia Wolf 
 
1.1 ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) IN ADULTS 
ADHD is characterized as one of the most common, pervasive, and impairing psychological 
disorders among children 1 and is one of the most thoroughly researched disorders in the field of 
medicine 2, affecting many aspects of functioning and development. The core symptoms of 
ADHD; inability to sustain attention, impulsivity, and hyperactive behavior; can significantly 
hinder success in social, academic, and home environments 3.  
The prevalence rate of ADHD ranges from approximately 3% to 9% of youth worldwide 4,5. 
Longitudinal data shows that 50%- 70% of children with ADHD continue to have symptoms as 
adolescents and adults 6,7. The decline in ADHD prevalence may be due to the finding that 
ADHD symptoms, especially hyperactivity, decline as a function of age 8. 
Despite the decrease in hyperactivity 6, adolescents and adults with ADHD continue to have 
impairing symptoms of inattention, hyperactivity, and impulsivity 9 and experience the same 
domains of functional impairment as children with ADHD 10. Academic 11, social 12 and family 
13 domains are frequently impaired in adolescents with ADHD. 
The diagnostic criteria for ADHD have been modified in the Diagnostic and Statistical Manual 
of Mental Disorders (5th ed; DSM-5 14) to better reflect the changing nature of the diagnosis 
throughout a lifespan 3. However, essentially the same symptoms as in DSM-IV 15 are retained 
in DSM-5 with some revisions. In order for individuals 17 and above to receive a formal 
diagnosis of ADHD according to the DSM-5, five or more symptoms of inattention and/or five 
or more symptoms of impulsivity/hyperactivity must be displayed before the age of 12 (six for 
individuals younger than 17 in each area respectively), without the requirement of creating 
impairment by age 12. In DSM-5, symptoms of inattention and/or impulsivity/hyperactivity 
must be evident in more than one context but do not have to cause functional impairment in 
multiple contexts. To be diagnosed, the symptoms have to interfere with, or significantly reduce 
the quality of, academic, social, or occupational functioning. Additionally, the severity level 
must be specified by the clinicians as either Mild, Moderate, or Severe.   
 
Three ADHD subtypes are used to categorize (adult) individuals: 
* Combined Presentation - for individuals who display at least 5 inattentive and 5 hyperactive-
impulsive symptoms in combination, while still meeting all the other diagnostic criteria.  
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* Predominantly Inattentive Presentation - when sufficient inattentive but insufficient 
hyperactive-impulsive symptoms are present. 
 
* Predominantly Hyperactive-Impulsive Presentation - when sufficient hyperactive-impulsive 
symptoms but insufficient inattentive symptoms are displayed.  
In adults, the cognitive and behavioral deficits include insufficient listening skills, being 
forgetful and easily distracted, difficulties in maintaining attention in paperwork, reading, 
finishing or initiating complex tasks at meetings, sitting through longer meetings, low 
frustration tolerance and making careless mistakes 16. 
The core ADHD symptoms of inattention, hyperactivity and impulsivity also contribute to the 
impairments in executive functioning, inhibitory control, working memory, and motivation. 
These neuropsychological deficits act as barriers for adults with ADHD in acquiring and 
implementing compensatory skills. This dysfunction in adaptive behaviors like organization and 
planning can lead to maintenance of the symptoms. 
After years of chronic underachievement and multiple failure experiences, adults with ADHD 
develop maladaptive negative cognitions and beliefs that negatively affect motivation and 
increase avoidance behavior and mood disturbance 17.  
 
1.2 ETIOLOGY 
The genetic background of ADHD is complex and the exact etiology is still unknown 18. 
Family, adoption and twin studies support the role of ADHD as a highly heritable disorder 18 
where heritability estimates as high as 90% 19 with direct polygenetic and environmental 
influence 20. Neuroimaging studies show maturation delay in cortical thickness in children with 
ADHD, most prominent in prefrontal regions. These regions are important for control of 
cognitive processes like motor planning and attention 21,22. Furthermore, the cerebellum, 
caudate, and prefrontal cortex have emerged as the essential areas displaying deficits in ADHD 
18. These regions are interconnected by a network or neurons, which are sensitive to the 
neurochemical environment. Additionally, they are sustained by neurotransmitters such as 
dopamine and norepinephrine, showing great importance in the regulation of attention, 
emotions, thoughts, behavior, and actions. Helpful pharmacotreatment in ADHD aims to restore 
the fine balance of the neurotransmitters in the prefrontal cortex 18. Moreover, the role of 
environmental factors as mediators or moderators of genetic have been explored in recent 
studies with inconsistent results 23. 
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1.3 COMORBIDITY AND RELATED PROBLEMS 
 
Comorbidity is common and up to 80% of the adults also fulfil the diagnostic criteria for 
depression, anxiety disorders, sleep disorders, and personality disorders 24,25. Other comorbid 
conditions are bipolar disorder, autism spectrum disorder (ASD) and eating disorders, although 
in a smaller number of cases 26. In adolescence and adult life, ADHD is shown to also have a 
negative impact on risky behaviors such as motor vehicle operation, substance abuse and sexual 
risk taking 27-29. 
Emotional regulation deficits are also implicated in ADHD 30,31 and brief recurrent depressive 
or dysphoric states or feelings of emptiness are all common in ADHD. When reviewing the 
literature, some authors finds the comorbidity between ADHD and borderline personality 
disorder of particular interest 32,33. Deficits in affect regulation, impulse control, substance 
abuse, low self-esteem and disturbed interpersonal relationship are similar problems between 
ADHD and borderline personality disorder. Mechanisms of affect regulation, however, differ 
quite dramatically in the two conditions. Unlike participants with borderline personality 
disorder who tend to show a “freezing behavior” or a “dissociative state” in emotionally 
stressful situations, participants with ADHD often try to regulate their labile emotional balance 
by excessive sports, sexual behavior, or sometimes impulsive aggressive behavior (“fight or 
flight”). Due to difficulties in impulse control and emotional instability, these participants are 
prone to interpersonal conflicts 34. 
 
In sum, adults with ADHD remain symptomatic and have the same and additional functional 
impairments and psychiatric comorbidities as children with ADHD. Despite the fact that adults 
with ADHD seek assessment and treatment in increasing numbers, there have been far fewer 
research studies that have focused on treating adults compared to studies on children with the 
disorder 35. 
 
1.4 TREATMENT 
 
1.4.1 Pharmacological treatment  
 
The majority of adults diagnosed with ADHD are offered pharmacological treatments as the 
major treatment option and few participants are given psychological treatment following 
completion of neuropsychiatric assessment and diagnosis 25.  Unfortunately, pharmacological 
treatment is not effective for about 20- 50% of the adults due to insufficient/lack of response 
and side effects 36,37.  
 
The 25 %–50 % of adults treated with medication who show improvement in core symptoms 
may still have residual symptoms in life domains such as education, work, life skills (e.g. 
driving), and relationships 17,38. Even though medication may help improve the basic symptoms 
of ADHD, this does not necessarily lead to overall functional improvement. The need for 
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complementary interventions such as psychological treatments for ADHD and its possible 
comorbid disorders should be emphasized 39-42. Thus, there is a clear need for effective 
treatments for adolescents with ADHD. When left untreated, costs for the individual and society 
are high.  
 
1.4.2 Psychological interventions 
Research regarding psychological interventions for adults with ADHD shows emerging 
evidence for cognitive behavior therapy (CBT) as a promising treatment approach 17,43-49. 
Dialectical behavior therapy (DBT), modified according the special needs of participants with 
ADHD, has also shown moderate to large effect sizes in the treatment of adult ADHD 34,50. A 
recent meta-analysis comparing psychosocial interventions and medication for adolescents with 
ADHD showed that behavior therapy produced the greatest effects on impairment and that 
medication produced the greatest effects on symptoms 51.  
Moreover, one study has shown that CBT produces greater improvements in ADHD symptoms 
when combined with pharmacotherapy, rather than CBT alone 52, findings in line with another, 
multimodal and multicentre study 53 showing better outcomes for psychological interventions 
when combined with methylphenidate over a 1-year period, as compared with placebo. Thus, 
CBT seems to be most effective as part of a multimodal treatment package.  However, more 
randomized controlled trials are needed to evaluate if effects found in treatment studies derive 
from specific treatment mechanisms or from non-specific mechanisms such as patient 
expectations and therapist credibility 54. Moreover, evaluation of long-term outcomes in the 
treatment of ADHD is limited 17.  
CBT for adults with ADHD includes behavioral interventions targeting the learning and 
practice of compensatory skills (requiring consistency and repetition), together with cognitive 
interventions for dealing with negative thoughts and resulting negative emotions which 
contribute to avoidance and procrastination 43. According to Safren’s cognitive behavioral 
model, neuropsychological deficits contribute to functional impairments over time, resulting in 
a history of underachievement and failures by hindering the individual from acquiring and using 
compensatory strategies 48. The compensatory strategies provided in the CBT programs usually 
include cognitive interventions such as cognitive restructuring, prioritization, organization, time 
management, dealing with procrastination, psychoeducation, problem solving, anger 
management, stress management, money management, relationship management, self-
instruction, and mindfulness 43.  
The emotional strategies (mainly used in DBT) include emotional regulation, impulse control/ 
self-control/self-regulation, self-motivation, emotional management, self-esteem, and self-
respect 34. These strategies may be used alone or in combination in any CBT program for adults 
with ADHD 17. 
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There are several reasons why CBT and DBT interventions may work for adults with ADHD. 
While some of them develop some effective ways of coping with the symptoms, most of the 
adults are unable to cope effectively with their deficits and are therefore unable to meet the 
demands of life. Moreover, they may be more motivated to seek treatment and be receptive to 
skill based treatments such as CBT due to their increased awareness of the deficits in their 
functioning 49,55. 
Furthermore, the main focus in CBT is on building skills to compensate for deficits in executive 
functioning and working memory 48. In DBT, change-oriented skills are used together with 
acceptance-oriented skills 50. A recently published study 56, blending individual sessions of 
DBT/CBT with group sessions, has shown promising effects for adults who respond only 
partially or not at all to drug therapy. However, the study was uncontrolled with a small sample 
size. Moreover, the content of the intervention is somewhat unclear in the article with only two 
CBT inspired sessions included in the intervention, and the conclusion is that the scope of CBT 
was rather limited when compared with Safren’s manual 57.  
 
Safren’s manual, together with Hesslinger’s, are the two most widely accepted and used 
treatment manuals for ADHD in Swedish psychiatric healthcare today. However, accessibility 
to these treatments is very limited due to a scarcity of therapist resources. Furthermore, due to 
the variety and complexity of adult ADHD, clinicians often choose to combine preferred 
techniques from both these manuals without knowing if this strategy leads to desired outcomes 
in therapy. In conclusion, there is a need to scientifically evaluate the effects of a treatment 
manual that combines techniques from both of these therapeutic treatments. A combination 
manual could offer adults with ADHD a treatment that addresses the variety and complexity of 
their ADHD related problems in a way that each manual, when used separately, most likely 
cannot do. 
 
1.4.3 Internet-based CBT  
 
Up until now, most of the evaluated treatment programs for adults with ADHD have offered a 
high degree of interpersonal support during treatment 58, which reduces accessibility to 
evidence-based interventions such as CBT due to limited therapist resources 59. However, in the 
last decade, internet-delivered cognitive behavior therapy (ICBT) has received increasingly 
robust empirical support as a treatment of various psychiatric conditions 60,61 such as depression 
62, pathological gambling 63, comorbid anxiety disorders 64, irritable bowel syndrome 65, social 
anxiety disorder 66, tinnitus 67, insomnia 68, generalized anxiety disorder 69, and panic disorder 
70. The ICBT treatment is provided through an internet-based treatment platform which 
comprises the same main components as conventional CBT. The interpersonal communication 
goes through text messages and the therapist generally has no face-to-face contact with the 
participants during treatment. 
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Internet-based treatments are a promising solution to a number of mental healthcare delivery 
problems. While many people with mental illness go untreated due to the scarcity of trained 
CBT-therapists, ICBT provides enhanced access to evidence-based treatments with 
interventions delivered through a self-help format. However, programs with therapeutic 
guidance are often more effective than unguided programs 71. Additionally, they can reach 
participants in areas where psychological or psychosocial treatment is not available. 
Furthermore, when compared with traditional face-to-face therapy, internet-based treatments 
have several other advantages in terms of greater cost-effectiveness 72, greater accessibility and 
convenience for the participants, as well as multimedia interactivity and continuous symptom 
monitoring.  
Interventions delivered through internet are already in use in the regular health care systems in 
several countries such as Sweden and Australia, and because of these advantages, it is 
reasonable to assume that they will become increasingly available and provide a valuable 
alternative to many face-to-face treatments in the future 71,73. 
 
1.4.4 Efficacy and use of smartphones in ICBT 
Despite their proven effectiveness, current ICBT programs leave room for improvement. One 
way to potentiate ICBT might be to add smartphone applications. Research has shown that there 
are around 165 000 health care applications available for patients today, and that patients are 
interested in using mental health applications in their clinical care 74. 
Smartphone applications bring the essential information, assignments, and 
measures/registrations much closer to the participants’ everyday lives where the most important 
work takes place to change behaviors, thoughts, and emotional reactions.  
The increased usage of smartphones creates an exciting and promising opportunity to extend the 
reach of psychological interventions and their effectiveness 75. The emerging smartphone 
technology supports practice and use of therapy interventions outside of the session and into the 
real-life situations.  
Smartphone applications may be used as stand-alone treatment or as supplementary ICBT 
components allowing novel features such as access to psychoeducational material, automated 
and tailored messages, reminders and feedback, as well as reporting of behaviors, thoughts and 
feelings unbiased by retrospective recall. The initial results from the relatively few studies on 
the use of smartphone in psychological treatment indicate that these interventions are effective 
75. Recently, a randomized controlled trial (RCT) contrasting smartphone- vs. computer-
delivered self-help for depression found equal improvements in the two groups 76. In another 
RCT 77, the effectiveness of two smartphone-delivered treatments was compared in the 
treatment of depression: one based on behavioral activation and other on mindfulness. After 8 
weeks of treatment, the participants in both treatment groups reduced their depression 
symptoms significantly and the groups did not differ from each other. Other trials have shown 
promising results for smartphone-based interventions mainly focusing on increasing physical 
activity 78, and smoking cessation 79, among others.  
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In sum, although the evidence base for smartphone-administered interventions still is limited, it 
can be assumed that the combination of smartphone applications and ICBT can enhance and 
potentiate the flexibility and effectiveness of cognitive behavior therapy in a near future.  
 
1.4.5 Self-help based treatments for ADHD  
 
In the treatment of ADHD, only a few studies have investigated the effect of a more self-help 
based treatment. Stevenson and colleagues examined the effect of a self-help based 
psychosocial intervention with minimal therapist contact in a randomized controlled trial 80. The 
participants were treated through a self-help book, containing education about ADHD and 
exercises covering strategies to cope with ADHD-related problems. Participants (n=35) were 
randomized to either a treatment group or a waiting-list control group. At the end of the 8-week 
treatment, the treatment group reported a significant reduction in ADHD symptoms, improved 
organizational skills and self-esteem and better anger control.   
Only one study has to date examined the effect of ICBT in the treatment of ADHD. In a 
randomized controlled trial 58, the efficacy of two iCBT program formats was evaluated, where 
self-help with minimal therapist contact was compared to the same self-help program with 
weekly group-therapy sessions and to a wait-list control in an outpatient psychiatric care. The 
results were promising in that both types of support provided a significantly better outcome than 
a wait-list control.  
 
The study by Pettersson and colleagues 58 indicates that self-help based psychosocial programs 
with a minimum of interpersonal support can also be a promising treatment alternative for 
adults with ADHD. However, there were several limitations of this study such as low power, 
lack of attention-matched control, and a dubious handling of missing data that inflated the 
treatment effects; all of which point to a need for further evaluations of ICBT for adult ADHD. 
 
1.4.6 The use of smartphone in the treatment of ADHD 
 
According to Hallberg 81, features such as alarm functions, calendars, to-do-lists, voice memos 
and camera can be useful tools for individuals with ADHD. A review of IT tools for adults with 
ADHD found that tools that give support for organization, structure and scheduling, and 
coordination of activities were the most desirable 82. Several of these tools are available in their 
analog form as parts of Safren's CBT treatment 57. Additionally, in a project conducted by inter 
alia Oslo university hospital, adult students with ADHD and Asperger’s syndrome learned to 
use a smartphone-based calendar synchronized with a computer. The result was a reduction in 
stress for the participants 83.  
 
 
 8 
 
1.4.7 Unmet needs  
 
The evidence base for the psychological treatment of adult ADHD is still limited and there is a 
need for more randomized controlled trials with larger sample sizes, active and credible 
controls, and long-term follow-up data, to provide evidence for the effectiveness of the 
treatment for this target group. Available interventions usually do not focus on the complexity 
and variety of problems related to the disorder and studies on psychological treatments usually 
separate CBT interventions from DBT in the treatment of ADHD.  Thus, there is a need to 
develop new treatment manuals that target the wide range of difficulties experienced by adults 
with ADHD.  
Furthermore, there are not enough psychologists and psychotherapists trained in CBT 59 in 
psychiatric healthcare. As a result, access to evidence-based psychological treatments is limited. 
Thus, given that the core symptoms of ADHD can lead to difficulties in a self-help based 
treatment setup, it is important to further develop and evaluate the efficacy of new technologies 
such as ICBT and smartphones in the treatment of ADHD in order to potentiate CBT and reach 
participants in areas where psychological or psychosocial treatment is not available. 
 
1.5 AIMS 
  
The primary aim of this thesis was to develop and evaluate the efficacy of new psychological 
interventions for adult ADHD, addressing a variety of related problems, with the intention to 
make these interventions accessible and available through internet.  
The following research questions are targeted in this thesis: 
 Are internet-based interventions a feasible way to treat adults with ADHD? (Study I and III) 
 Can the use of smartphone applications teach adults with ADHD to improve their attention 
and organization skills? (Study I) 
 Is a new treatment manual for adults with ADHD, combining methods from CBT and DBT, 
feasible and effective in reducing ADHD symptoms in adults? (Study II-III) 
 Does the combined treatment manual produce specific or non-specific effects?  (Study II-III) 
 What are the long-term effects for the combined treatment? (Study II-III)
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2 METHODS 
 
“I wish I could show you, when you are lonely, or in darkness, the astonishing light of your own 
being.” ~ Hafez 
 
In each section below, elements that were shared between the studies are presented first, 
followed by a description of the unique and specific elements for each study.  
 
2.1 DESIGN 
 
Study I-III were clinical trials, conducted at the Internet Psychiatry Clinic at Psychiatry 
Southwest in Stockholm, Sweden.  
Study I. In this randomized controlled study, 57 participants were randomized to either an 
internet-based course, teaching adults with ADHD or probable ADHD how to structure their 
everyday life through smartphone applications and online tools, or to a wait-list in a 1:1 ratio. 
The wait-list received the online course without therapeutic support after the post assessments. 
Assessments were made pre and post intervention. The primary outcome measures were also 
filled out weekly by the participants. 
Study II was an uncontrolled pilot study where 18 participants underwent a 14 week 
intervention based on a manual combining CBT and DBT components. Assessments were made 
pre, post, one and six months after intervention. 
Study III. In this randomized controlled study, 104 participants were consecutively randomized 
to either ICBT including a smartphone application to organize everyday life (n=36), to an 
equally long and active control treatment consisting of internet-based applied relaxation training 
(IART; n=37), or to treatment as usual (TAU; n=31). Assessments were made pre, post, three, 
and twelve months after intervention.  
 
2.2 PARTICIPANTS 
Recruitment of participants into study I was conducted through social media, postings on the 
National Association of Neuropsychiatry’s website in Stockholm and via information on the 
website of Internet Psychiatry Clinic within Stockholm County Council.  Participants in study 
II-III were enrolled through specialized neuropsychiatric units in Stockholm, and in study III 
also via the same sources as in study I.  
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Shared inclusion criteria in study I-III were: 
 Aged at least 18 
 Confirmed (or in study I, probable) diagnosis of ADHD according to DSM-IV or DSM-5 
 Score of 17 points or more on the inattention and/or the hyperactivity/impulsivity subscale of 
Adult ADHD Self Report Scale version 1.1 84 (ASRS v1.1; only the inattention scale for 
study I) 
 Ability to participate in the study  
 
Shared exclusion criteria in study I-III were: 
 Severe depression as assessed by clinician (study II-III) or by scores greater than 30 in study 
I or greater than 34 in studies II and III, using the self-rated Montgomery-Åsberg Depression 
Rating Scale 85,86 (MADRS-S)  
 Suicidality 
 Somatic or psychiatric conditions that could seriously hamper participation in treatment 
 ongoing non-pharmacological treatment for ADHD 
 substance misuse (study I) during the last three months (study II-III) 
 
Furthermore, in study I and III, common inclusion criteria were internet and smartphone access 
and ability to understand and read Swedish. In study II-III, stable or no psychotropic medication 
one month before baseline was required. Participants were also excluded in case of organic 
injury, and IQ ≤70 (study II) or IQ lower than 85 (study III). The final exclusion criterion in 
study III was a diagnosis of level 2 or 3 autism spectrum disorder according to DSM-5. 
 
Baseline characteristics of the participants. A full comparison of the baseline characteristics 
can be seen in Table 1. Mean age ranged between 36-40 years, and a majority of the participants 
in the internet studies (I and III) were women. Sixty-one to eighty-three percent were stabilized 
on pharmacotherapy for ADHD before entering the studies. Furthermore, a majority of the 
participants worked/studied in all studies and had a high school (study II) or college/university 
degree (study I).  
Comorbidity was most prevalent in study II where a majority of the participants had at least one 
comorbid disorder. Pretreatment scores of ASRS v.1.1 were similar between participants in 
study I-III, and most of the participants had a combination form of ADHD. 
 
 
 
 
 
 
 11 
 
Table 1. A comparison of demographic characteristics of participants at baseline for the treatment studies 
 
 
Baseline characteristics 
 
 
    I 
Living Smart 
(N=29) 
    II                  
Group 
treatment 
(N=18) 
III 
ICBT 
(N=36) 
  III 
IART 
(N=37)  
Sociodemographic 
 
    
 
 
Gender  
 
Women 22 (76%) 8 (44%)  25 (69 %) 30 (81 %) 
 
 
Age  
 
Mean (SD) 36.32 (11.1) 39.71 (8.2) 36.72 (11.4) 35.97 (9.4) 
 
 
 
 
Highest education  
 
Elementary school 1 (3%) 4 (22%) 2 (6 %) 6 (16 %) 
High school  11 (38%) 10 (56%) 16 (44 %) 15 (41 %) 
College/University/Other 17 (59%)  4 (22%) 18 (50 %) 16 (43 %) 
 
 
 
  
Occupational statusa 
 
Working/studying 23 (67%)  13 (72%) 25 (70 %) 23 (62 %) 
Sick leave/disability retired 6 (21%) 3 (17%) 7 (19 %) 9 (24%) 
Unemployed 2 (7%)  2 (11%) 3 (8 %) 4 (11 %) 
  Parental leave/housewife or 
house husband 
3 (10%) 0 (0%) 1 (3 %) 1 (3 %) 
Clinical 
 
     
 Level of ADHD 
symptoms 
 
ASRS v1.1 mean (SD) 50.6 (8.5) 45.8 (11.2) 48.5 (9.5) 48.7 (9.0) 
 Level of depressive 
symptoms 
 
MADRS- S mean (SD) 
 
7.1 (4.2) 15.1 (7.8) 16.4 (8.3) 15.4 (8.8) 
 
 
 
Subtype ADHD  
 
Combined 20 (69%) 13 (72%) 31 (86 %) 34 (92 %) 
Inattention 5 (17%) 5 (28%) 5 (14 %) 3 (8 %) 
Hyperactive 0 (0%) 0 (0%) 0 (0 %) 0 (0 %) 
  Not reported 
 
4 (14%) 0 (0%) 0 (0 %) 0 (0 %) 
 Psychiatric   Any diagnose  8 (28%) 11 (67%)  7 (19 %) 5 (14%) 
  Depression 2 (7%) 5 (28%) 5 (14 %) 6 (16 %) 
  Bipolar disorder 2 (7%) 4 (22%) 2 (6 %) 5 (14 %) 
  Anxiety disorder 3 (10%) 3 (17%) 12 (33 %) 10 (27 %) 
  Autism spectrum disorder 2 (7%) 3 (17%) 4 (11%) 2 (5%) 
  Eating disorder 0 (0%) 0 (0%) 1 (3 %) 0 (0 %) 
  Personality disorder 
 
0 (0%) 1 (5.5 %) 1 (3 %) 0 (0 %) 
 
 
ADHD medication  
 
Stimulants and/or non-
stimulants 
24 (83%) 13 (72%) 22 (61%) 25 (68%) 
 
 
Antidepressant 
medication 
Any 7 (24%) 7 (39%) 6 (17 %) 12 (32 %) 
      
Note: ICBT= Internet-based Cognitive Behavioral Therapy, IART= Internet-based Applied Relaxation Training, TAU= 
Treatment As Usual, ASRS= Adult ADHD Self Report Scale v1.1; MADRS-S = Montgomery-Åsberg Depression Rating 
Scale (self-report version). 
a Multiple choice question, e.g. can be working and partially on sick leave 
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2.3 ASSESSMENTS 
 
2.3.1 Diagnostic assessments 
 
In all studies, licensed clinical psychologists and/or supervised final year clinical psychology 
students performed the diagnostic evaluations of the participants in the studies. The primary 
consideration in making participant eligibility decisions was a confirmed ADHD diagnosis. 
Therefore medical records and previous neuropsychiatric assessments were examined by the 
researchers to confirm their diagnostic status. If these could not be found, a copy of a 
neuropsychiatric report and/or a medical certificate was requested from the participant in order 
to determine eligibility to the study. Further evaluation of participant’s current level of 
impairment and ADHD symptoms were made through ASRS-v1.1 84 in all studies.  In order to 
be included, participants also needed 17 or more points on the inattention or hyperactivity 
subscale using this measure (only the inattention scale for study I).  
The specific diagnostic procedures for each study is described below. 
 
Study I. ADHD diagnosis was confirmed through medical records for 29 (51%) of the 57 
included participants. In cases where medical records were unavailable for evaluation, ADHD 
was evaluated through the DSM-IV diagnostic criteria in a structured telephone interview 
without performing neuropsychological testing or going through childhood anamnestic 
information in these cases.  
After the telephone interview, an additional 28 individuals (49%) were deemed to have a very 
probable/probable ADHD diagnosis. However, due to bureaucratic delays, evaluation of 
medical records was performed after decision of inclusion in some cases. Thus, for 7 (12%) of 
the included participants who first were deemed to have a probable diagnosis after the telephone 
interview and thus were included in the study, diagnosis was not verified.  
 
Study II.  Medical records confirmed ADHD for all the participants in this study. Except for the 
ASRS v.1.1, clinician-rated ADHD Rating Scale IV for adults 87 was used during the 
assessment interview which preceded inclusion to the study, mainly to assess change in 
symptom severity from pre to post treatment. 
 
Study III. Participants were only included if their ADHD diagnosis could be confirmed. In 
cases where verification of the ADHD diagnosis was not possible through medical records, a 
copy of a neuropsychiatric report and/or a medical certificate was requested from the participant 
in order to determine eligibility to the study. The ADHD Rating Scale IV was also used in this 
study during the assessment interview mainly to asses change in symptom severity. All the 
participants included had a verified ADHD diagnosis. 
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2.3.2 Outcome measures 
 
This section describes a selection of the outcome and process measures most relevant for this 
thesis. 
 
Primary outcome – self-rated ADHD Symptoms. Adult ADHD Self Report Scale version 1.1 
(ASRS-v1.1, abbreviated as ASRS in this thesis) 84 was used as the primary outcome in Studies 
I-III, using the full scale ASRS as primary outcome in study II-III, and the inattention subscale 
for study I.  
ASRS is a self-rating scale, containing the 18 symptom items for ADHD from the DSM-IV 15. 
It includes two subscales, one measuring problems with inattention (nine questions), the other 
measuring problems with hyperactivity and impulsivity (nine questions). The options in the 5-
point Likert scale are “never” (0), “rarely” (1), “sometimes” (2), “often” (3), or “very often” (4), 
as response types. The maximum score of ASRS is 72 and 36 points on the two subscales 
Inattention and Hyperactivity/Impulsivity, respectively. Test–retest reliability of ASRS is 0.88 
88. Treatment response was defined as a reduction of at least 30% in the score of ASRS 39. 
 
Clinician rated ADHD symptoms. The ADHD Rating Scale – IV 89 was administered in 
studies II-III. This measure consists of 18 items based on the DSM-IV criteria for ADHD, with 
the same response options as ASRS. It is a widely used clinician rated scale with acceptable 
psychometric properties 90. 
Clinical Global Impression – Improvement scale (CGI-I) 91. Blinded clinicians in studies I 
and III rated post-treatment change in participant’s illness severity relative to their baseline 
rates, using this 7 point scale ranging from 1 (very much improved) to 7 (very much worse). 
CGI-I is widely used in clinical research and medical care due to its face validity and 
practicability 92. Clinical significant change was defined as much or very much improved. 
 
Depression. In study I, researchers administered the Hospital Anxiety and Depression Scale 
(HADS) 93; a self-report scale with good internal reliability using 14 items and two subscales to 
measure anxiety (HADS-A) and depression symptoms (HADS-D). Each subscale consists of 
seven questions (scores 0–3) with 7 or more points as cut-off. The scale has a sensitivity of 
0.66, and a specificity of 0.97 to detect depression 94. Only results for HADS-D is reported in 
this thesis. 
Furthermore, Montgomery Åsberg depression rating scale – self rated version (MADRS-S) 85,86 
was used to measure depression severity in study II-III.  In these studies, MADRS-S was also 
administered weekly to detect suicidal ideation and risks. This instrument is widely used and 
validated for detecting and measuring change in depression severity. The MADRS-S contains 
nine items (scored 0-6) with total scores ranging from 0 to 54.  
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Level of functional impairment. To measure level of functional impairment (everyday 
functioning) in three life domains; work/school, social and family life, the Sheehan Disability 
Scale (SDS) 95 was used. Each domain score from 0 (not at all) to 10 (very much), reflects 
participants’ level of impairment in these areas. Total score ranges from 0-30 (severely impaired 
level of functioning). This scale is sensitive in detecting treatment effects and has shown good 
psychometric properties 96. 
Degree of stress. The Perceived Stress Scale (PSS) is a widely used psychological instrument 
for measuring degree of experienced stress in different life situations 97. The PSS version used 
in study I had 10 items with response alternatives 0 (never) to 4 (very often) and an internal 
reliability of a Chronbach's alpha of 0.89. The 4-item version, also with acceptable 
psychometric properties 98 was used in study II-III. 
 
2.3.3 Process measures 
 
Adherence measures 
Modules/sessions completed and therapist time spent on each participant  
An analysis of how many modules/sessions each participant had completed during intervention 
was made in studies I-III. Furthermore, total therapist time spent on each participant reading and 
answering messages in the internet platform was analyzed for study I and III, as well as duration 
of supportive telephone calls to the participants in study II-III (planned weekly in study II). 
Changes in medication and engagement in other therapeutic interventions. At post treatment, 
all participants in all studies were asked if they had made changes in their ADHD medication 
and/or had engaged in other therapeutic intervention related to their ADHD during their 
participation in each intervention. 
Treatment credibility and satisfaction. Credibility was assessed with Treatment Credibility 
Scale 99 in study III for both treatment groups. The scale consists of five 10 point items. It 
assesses participants’ perception of treatment credibility and how successful they deem the 
treatment will be in alleviating the target problems. The range of the test-retest reliability is 
between 0.75 and 0.82 and the internal question consistency (Cronbach’s a) is between 0.69 and 
0.83 100.  
 
Furthermore, client satisfaction was measured in studies II-III with the Client Satisfaction 
Questionnaire (CSQ-8) 101, consisting of eight items in which the item score ranges on a scale 
from 1-4 with a total possible score of 32. This scale has good internal consistency, is sensitive 
to treatment, and has good retest reliability 102. 
Use, benefit and understanding of the treatment components. In study II, a questionnaire 
designed specifically for the study was used to measure the degree of use, understanding, and 
perceived utility of the treatment components. Previous session and homework assignments 
were rated by the participants each week by answering three questions related to each treatment 
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component. These questions assessed degree of use, benefit, and understanding of the 
components in each session. For use and benefit, the response options were: not at all (0), a little 
(1), to some extent (2), a lot (3), and very much (4). For level of understanding 
(comprehension), the response options were very difficult (0), difficult (1), neither difficult nor 
easy (2), easy (3), and very easy (4).  
 
Furthermore, when reviewing homework, clinicians used the same 0-4 scale to rate participant’s 
degree of use, benefit, and understanding. In order to enable comparisons between treatment 
components, the mean of all ratings of benefit and understanding was used. Total use of each 
component was summed considering that some of the components (e.g. the Safren components) 
were used more during treatment due to the treatment setup. Thus, these components received 
more weekly ratings and consequently higher totals. Finally, components that belong to either 
Safren’s or Hesslinger’s interventions were merged into two blocks (Organizing and DBT), and 
all the mindfulness exercises were merged into one block (Mindfulness). 
 
2.4 INTERVENTIONS 
In study I and III, the same internet platform was used to deliver the interventions. In study II-
III, a novel treatment based on established therapeutic methods from CBT and DBT was 
evaluated.  
The internet-based interventions. All of the internet-based interventions described in this 
section were developed and delivered through the Internet Psychiatry technical platform. After 
gaining access to the internet platform with a secure, double authentication log-in through 1177 
(a governmental national eHealth site), participants took part of the course/treatment materials 
and secure messaging system in order to communicate with their therapist. The interventions 
were built on text-based chapters (modules) and in general, participants were instructed to work 
with each module for one week. Each module was devoted to a specific theme, was alternated 
with interactive work-sheets and ended with homework assignments. In addition, quick and 
often self-reflective exercises were built in the modules in study III to increase variation. After 
completing these, the work was sent to the therapist who reviewed the material and provided the 
participant written feedback and access to the next module often within 36 hours. In addition to 
the course/treatment materials, participants also filled out weekly web measures before getting 
access to the modules. This allowed the therapist to monitor symptom change during 
intervention. ADHD symptoms were rated weekly by the participants in study I and III. 
However, study III also used the MADRS-S to monitor progress and detect risks. Four points or 
higher on MADRS-S 85 suicide ideation item led to an additional structured telephone 
assessment by a clinician. In case of inactivity, participants were reminded and encouraged to 
continue their work via web-messaging or a personalized mobile text message. A phone call 
was made if this did not lead to resumed activity. Participants were also encouraged to write to 
their therapist whenever they needed support regarding their work. 
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Content of the combined treatment.  The treatment manual evaluated in study II-III was 
developed by the author of this thesis. The first “block” of treatment addressed executive 
dysfunctions and was mainly based on Safren’s manual 57. The second “block” of treatment was 
based on Hesslinger’s DBT treatment 103, with some adjustments in content. The mindfulness 
exercises were provided from Hogrefe Publishing House. Moreover, the author added other 
components to the manual such as valued living inspired by Acceptance and Commitment 
Therapy, 104 and communication training. In study III, a module on sleep hygiene was added to 
the treatment. The components are described in detail in Table 2. 
 
Table 2. Content of the combination treatment 
Content Description 
Psychoeducation Prevalence, etiology, symptom description, evidence 
based treatments and content description 
Attention training (Mindfulness) Paying attention to thoughts and feelings without 
judging. Practicing self-compassion and acceptance.  
Valued Living  Setting up personal goals as desired treatment 
outcomes. Learn how these goals can be rooted in 
deeper values (inspired by Acceptance and 
Commitment Therapy). 
 
Planning and organizing everyday life Learn how to use to do-lists and prioritize activities. 
Break down activities to reduce procrastination. 
Incorporate the to-do list in a calendar. Use efficient 
reminders. 
 
Behavior analysis Understanding and changing dysfunctional behavior 
patterns. 
Impulse control Increasing control over dysfunctional patterns due to 
impulsivity. 
Emotion regulation Learning about basic emotions and their values. 
Practicing how to regulate emotions through self-
monitoring and self-validation.  
 
Communication Practicing communication skills in order to enhance 
listening and participating during conversations. 
Sleep hygiene Learning about a variety of habits and practices that 
enhance good nighttime sleep quality as well as full 
daytime alertness (only in Study III). 
Problem solving Using problem solving as a tool to increase mental and 
behavioral flexibility when dealing with obstacles in 
everyday life (only in Study II). 
 
Relapse prevention Learning about how to prevent setbacks and relapses.  
Planning how to work with achieved skills after 
treatment. 
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2.4.1 Study I – Living Smart 
 
The content of the course Living Smart was inspired by specific parts of an existing manual for 
ADHD 57 and on the findings from previous studies regarding important IT tools for ADHD 81-
83. During the six-week therapist guided program, participants took part of seven chapters (text 
modules) where they learned how to use different online and smartphone applications in order 
to enhance their attention and organization skills. The main focus of the course was an online 
calendar app named Google Calendar. The content of the course modules, including all 
smartphone applications and their functions, are presented in Table 3. 
 
Table 3. Content of Living Smart. 
Module Content Smartphone Application 
1 Introduction to the course, goal setting  
2 Introduction to Google Calendar, shared calendar and 
weekly planning 
Google Calendar (Time 
management) 
N-back (improving working 
memory) 
3 Smartphone calendar, using reminders, daily planning Google Calendar 
Evernote (Notes to aid memory) 
4 Using to-do-lists, working with difficult tasks G-tasks (to-do-list) 
Google Tasks (organization) 
5 Reducing distractions and stopping procrastination Stayfocusd (block distractions) 
SimplyNoise (reduce 
distractions) 
6 Problem solving, advanced features and repetition Dropbox, Banking apps 
7 Summary of the course, planning for the future All applications 
Note. Reproduced with permission from Elsevier. 
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2.4.2 Study II – The combination treatment 
 
The group treatment lasted 14 weeks and each session followed the same structure. The weekly 
three hour session was led by one senior therapist and one co-therapist. They started with a 
mindfulness exercise and were followed by a homework review from the previous session. 
Participants’ degree of use, comprehension, and benefit, were also rated by two observers. After 
a 15-minute break, the new session theme (described in Table 2) was introduced through power 
point and white board, and at the end of the session, new homework assignments were given to 
the participants. The assignments were tailored later during an individual phone call, placed by 
one of the therapists 2-3 days after the group session. These calls focused on support and 
solving problems related to treatment. Participants were instructed to work 30-60 minutes per 
day with their homework assignments. As a reminder to attend the session, a text message was 
sent to the participant´s mobile phone the day before. During the sessions, target behaviors such 
as attention training, impulse control and time management were practiced in group, however, 
participants were encouraged to use these skills beyond the session context as well.  
 
2.4.3 Study III – Internet-based treatment for adults with ADHD 
 
ICBT and IART were given as add-ons to treatment as usual. Both treatments lasted 12 weeks 
and were further matched for treatment format, number of standard modules given to the 
participants, therapists, and their supervision. 
 
Internet-based cognitive behavior therapy (ICBT). ICBT was based on the combination 
manual described in Table 2. Mindfulness exercises were conveyed through audio clips. 
Thirteen standard and two optional modules were available. Additionally, a new smartphone 
application inspired from applications from study I was developed and used in ICBT as an aid 
to organize daily life. This included a flexible to-do list where tasks were categorized, 
prioritized, and managed, with functions for calendar-scheduling, reminders, and planning 
techniques. These features were intended to replace web-work sheets in Safren’s modules. In 
case of treatment inactivity, the therapist sent an encouraging text message after 2-3 days and if 
the participant remained inactive, he/she was contacted by telephone.  
 
Internet-based applied relaxation training (IART). This treatment was designed as an active 
control treatment with a thorough and credible rationale, based on the well-established 
relaxation program, applied relaxation 106. This program has shown effects similar to traditional 
CBT for conditions such as generalized anxiety disorder and panic disorder 107-109. 
In a study of adult ADHD, relaxation was used as control treatment 39, with inferior effects 
compared to individual CBT sessions. The intervention was presented as a stress reducing 
technique aimed at breaking the vicious circles fueled by ADHD symptoms.  
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Treatment as usual (TAU). The treatment as usual condition consisted of each participant’s 
standard medication and/or standard psychiatric care. Participants were only contacted for 
assessments. Initially, 71% of participants were undergoing ADHD medication. 
 
2.5 STATISTICAL ANALYSIS 
All analyses were performed according to intent-to-treat. T-tests and Chi-squared tests were 
conducted to compare the groups at baseline. Effect sizes were calculated as Cohen’s d (study I) 
and Hedges’ g (study II-III). The significance level set for all statistical analyses was p < .05.  
Study I. Outcome differences were analyzed through a two-way repeated measures ANOVA, 
with time (pre-post) as within subject variable and group as between subject factor.  
Additionally, sensitivity analyzes for all of the outcome measures were conducted without 
including the seven participants who did not fulfill all criteria for ADHD. At post treatment 
assessments, last-observation-carried-forward was used to replace missing data for the primary 
outcome to evaluate the effect of missing data. 
Study II. Primary outcome was analyzed through a one-way repeated measures ANOVA 
including four time-points (pre, post, one month, and six months follow-up), and Bonferroni-
corrected post-hoc tests were used to evaluate differences between the pre-measure and each 
following time-point. An ANOVA was also used to compare differences between use, 
comprehension, and benefit for all the treatment components. Moreover, their relationships with 
various outcome measures were analyzed with Pearson’s correlations.  
Study III. Hierarchical Linear Mixed-effect models were used to test if change over time 
differed between groups. Since TAU had received treatment after the three-month follow-up 
and thus could not act as a control group at the 1-year follow-up, two separate models were 
used. The first model included all groups but only used the data from pre, post, and three month 
assessments.  
Two dummy variables were used to compare each active treatment to TAU, which was set to 
zero in both dummies. The second model included only ICBT and IART and compared their 
slopes over a time period covering all the assessment points (pre, post, three and twelve 
months). The best model fit was found when random intercept, random slopes, and a squared 
time parameter was included. A sensitivity analysis included the baseline variables that were 
correlated to missingness, to control for non-random missing data.  
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3 RESULTS 
 
“If it doesn’t challenge you, it doesn’t change you.” ~ Fred Devito 
 
3.1 STUDY I 
 
3.1.1 Primary outcome 
From pre to post treatment, participants in the Living Smart condition showed a significantly 
larger decrease in the ASRS subscale for Inattention when compared to the wait-list condition 
(p < .001). The sensitivity analysis in which the seven participants without an ADHD diagnosis 
were removed did not alter the results. The within group effect size was large (d=1.18) as well 
as the between group effect (d=1.21).  
3.1.2 Secondary outcomes 
Participants in Living Smart condition improved significantly on hyperactivity and depressive 
symptoms compared to wait-list (p < .05), although the between group effect sizes were small 
(d=0.19-0.23). No significant interactions were found on experienced stress or level of 
functional impairment. Eight participants (33%) reached a clinical significant change according 
to blinded ratings on CGI-I, mainly assessing improvement in attention and organization skills. 
No participant in the wait-list group made a clinically significant change. 
3.1.3 Process measures 
Participants completed on average 3.7 of the seven modules (53%). Each week the therapist 
spent on average 8.5 min on each participant in the platform. No correlation between therapist 
time spent and change in outcome was found. Changes in medication or engagement in other 
therapeutic intervention did not differ between the groups. Furthermore, many participants 
requested a longer treatment time in the qualitative evaluation. 
 
3.2 STUDY II  
 
3.2.1 Primary outcome 
Participants improved significantly regarding ADHD symptoms between pre and post 
treatment, using full scale ASRS v.1.1 as primary outcome (p < .001). Within effect size was 
large at post (d=1.29). Improvements were maintained and still significant compared to baseline 
at both follow-up assessments; one and six months after treatment (d=1.45-1.35). Post treatment 
responder analysis identified 11 participants (61%) as responders.  
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3.2.2 Secondary outcomes 
Significant improvements were observed at post treatment for all secondary outcome measures 
assessing depression severity, degree of stress, level of functional impairment (p < .05), and 
clinician rated ADHD symptoms (p < .01). Within group effect sizes ranged from moderate to 
large (d=0.45-1.46).  
 
3.2.3 Process measures 
On average, participants completed twelve of the fourteen sessions (86%). Each weekly 
telephone conversation with the participant lasted about 20 min. Moreover, average ratings of 
participant’s satisfaction with treatment were 29.33 (SD= 4.28) out of maximum 32, which was 
considered to be “excellent satisfaction” 110. 
Organizing components were rated by the participants as more used and comprehensible than 
DBT (p < .01). Organizing was also rated as more comprehensive and beneficial than the 
Mindfulness block (p < .01). Change in ASRS correlated significantly with total use of all 
treatment components (r = 0.51; p < .05). Moreover, the usage of Organizing and DBT 
components correlated significantly with reductions in ADHD symptoms, but this relationship 
was not found with the Mindfulness component. No change in medication or engagement in 
other therapeutic interventions was reported by the participants at post treatment assessments. 
 
3.3 STUDY III 
3.3.1 Primary outcome 
ICBT and IART showed a larger reduction in ASRS comparing to TAU over the period from 
pre to three month follow-up (p < .01). Between groups effect size for ICBT was moderate 
(d=0.42) as for IART (d=0.57). However, the treatment effects were similar without any 
significant interaction between the two treatment groups when compared over all four 
assessment points, showing that both treatments were equally effective in reducing ADHD 
symptoms. Response rate was 25% in each treatment group compared to 3% in TAU at post 
treatment.  
3.3.2 Secondary outcomes 
When comparing all three conditions, there was a significantly larger reduction in clinician 
rated ADHD symptoms over time for ICBT and IART (d=0.35-0.40; p < .001) in comparison to 
TAU. Furthermore, ICBT showed superiority over TAU for depression severity, (d=0.6;  
p < .01) perceived stress (d=0.07; p < .01 and level of functional impairment (d=0.45; p < .01), 
while IART did not.  
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When comparing ICBT to IART from pre to one year after treatment, no significant interactions 
were found except for level of functional impairment favoring ICBT  
(p < .01). According to blinded ratings, 30% of participants reached clinically significant 
change on CGI-I in ICBT after treatment, compared to 9% in IART, when assessing 
improvement on ADHD symptoms in total. The difference was not significant (p=.14, Fisher’s 
exact test).  
 
3.3.3 Process measures 
 
On average, participants in both treatment groups completed seven of the 13 standard modules 
(56%). Total weekly therapist time spent per participant reading and answering messages was 
on average 11.2 minutes in ICBT and 7.3 minutes in IART, which was significantly less  
(p < .01). In total, duration of each telephone call from therapist to the participant was 17.1 
minutes in ICBT, significantly longer than the 7.3 min in IART (p < .01). Overall rates for 
satisfaction were higher for ICBT than the control treatment, and ICBT were also deemed as 
more credible after five weeks of treatment. 
No differences were found between the groups regarding change in ADHD medications and/or 
engagement in other therapeutic activities. 
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3.4 SUMMARY OF RESULTS 
 
Figure 1 illustrates change on the primary outcome for study I-III and Table 4 summarizes the 
number of patients and effect sizes (with confidence intervals) for ADHD symptoms, 
depression and level of functional impairment for study I-III. As a reference, some data from 
the previously published ICBT study 58 are also included in the table. Response rates are also 
compared between studies. 
 
 
Figure 1. Change on ASRS v1.1 from pre-treatment to post-treatment – a comparison between study  
I-III, observed means. 
 
3.4.1 Attrition 
 
In study I, response rate for Living Smart was 90% and 96% for the wait-list control at post 
treatment assessments. In study II, response rate was 100% at post, 83% at one month follow-up 
and 100% at six month follow-up assessments.  
 
In study III, the total response rates at post was 90%; for ICBT 89%, IART 86% and TAU 97%. 
At three month follow-up assessments, the total response rate was 86%; for ICBT 78%, IART 
84% and TAU 97%. Finally, the total response rate at twelve months follow-up was 79%; for 
ICBT 81%, and for IART 78%.  
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Table 4. Within group effect sizes and number of treatment responders 
Study  N a  Total ASRS   ADHD Symptoms 
(ASRS/CSS) 
Follow-up c 
 ADHD Rating Scale  Depression g  Sheehan Disability 
Scale 
 Responders 
 
    Effect b 95% CI  Effect b 95% CI  Effect b 95% CI  Effect b 95% CI  Effect b 95% CI  ASRS d CGI-I e 
I 
Living Smart 
 
 
29   0.72 0.15-1.28        
 
 
0.11  -0.43 - 0.65  0.47 -0.08 - 1.02  4 
(17%) 
8 
(33%) 
II 
Group 
Treatment 
 
 
18  1.29 0.54 -2.01  
 
1.35  0.63 -2.07  1.46 0.73 -2.20  0.45 -0.23 - 1.13  0.76 0.08 - 1.43  11 
(61%) 
 
 
III 
 
 
                   
 ICBT   36   0.68 0.19 -1.17  
 
0.79  
 
0.29 -1.30  0.79 0.24 -1.34  0.62 0.12 -1.12  0.82 0.31 - 1.34  8 
(25%) 
7 
(30%) 
 IART  37   0.93 0.43 -1.42  0.92
  0.41-1.43  0.79 0.25 -1.32  0.33 -0.15 - 0.82  0.35 -0.13 - 0.84  8 
(25%) 
2 
(9%) 
Previous ICBT 
study 58 
 
 
                   
 iCBT-G  14  
 
0.42 f -0.33 -1.16  
 
0.41  - 0.34 -1.16     0.52  -0.23 - 1.27       
 iCBT-S 
 
 
 13  0.61 e -0.18 -1.40  0.57 -0.21 -1.35     
 
0.24  -0.53 -1.02       
Note: The table contains data that has not been reported previously. Abbreviations: ASRS= Adult ADHD Self Report Scale v1.1; CSS= Current Symptoms Scale (self-report); CGI-I=Clinical Global Impression – Improvement Scale. ICBT= Internet-based Cognitive Behavior 
Therapy. IART= Internet-based Applied Relaxation Training; iCBT-G=Internet-based Cognitive Behavior Therapy-Group format; iCBT-S= Internet-based Cognitive Behavior Therapy-Self-help format. 
a Sample size at intervention/treatment start 
b Within group effect sizes comparing pre to post and pre to six or twelve month follow-up, shown as Hedge´s G, based on observed, non-imputed m and SD (pooled) 
c  Follow-up assessment points: study II and previous ICBT study = six month follow-up; study III = twelve month follow-up. The effect size for the ASRS at six month follow-up has been corrected since it was found inaccurately reported in Table 3 in the published article 
(study II)  
d 30% reduction or more on total ASRS 
e Clinical significant change defined as much or very much improved on CGI-I (for study I, only change in inattention and organization problems). 
f ADHD-symptoms assessed with CSS 
g Effect sizes for Hospital Anxiety and Depression Scale  (HADS-D) in study I, Montgomery-Åsberg Depression Rating Scale (MADRS-S; self-report version) in study II-III,  and Beck Depression Inventory (BDI-II) for the previous ICBT study 
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4 DISCUSSION  
 
“She had not known the weight until she felt the freedom.” ~ The Scarlet Letter 
 
4.1 Are internet-based interventions a feasible way to treat adults with ADHD?  
The very nature of symptoms like inattention, impulsivity, and hyperactivity, can undoubtedly 
interfere with the delivery of internet based interventions to patients with ADHD. Thus, one of 
the main objectives of this thesis was to investigate the feasibility aspects of the treatment 
format.  
In conclusion, results from studies I and III show that internet treatment seems to be a feasible 
treatment format - but with some caveats. In total, therapist spent between 8.5 (study I) -11.2 
(study III) minutes weekly per participant reading and answering messages. The treatment 
credibility for ICBT was higher than in the control condition after five weeks of treatment, with 
satisfaction ratings on par with the ratings in study II, indicating “excellent” treatment 
satisfaction 110. This suggests that ICBT is a feasible treatment format for this participant group. 
Results from study I and III also show that internet-based psychological interventions have the 
potential to improve ADHD symptoms with moderate (study III) to large (study I) within group 
effect sizes on the primary outcome and less therapist time compared to “conventional” face-to-
face behavioral interventions for ADHD 48,111. A majority of participants had ongoing 
medication for their ADHD symptoms, indicating that the achieved treatment effects most 
likely were add-on effects to medication. This is promising, considering that pharmacotherapy 
has been shown to be insufficient for 50-70% of the participants 37. 
 
Moreover, there are even some clear advantages of internet-based interventions over face-to-
face treatment for this group of participants. For example, while inattention may cause ADHD 
patients to miss relevant information in traditional therapy sessions, the possibility to work at 
home with the treatments and taking short breaks while working with the material can be a 
better fit for their attentional style. Furthermore, the text format makes it possible for the 
participants to repeat and retain the treatment content for later use; clear advantages for a patient 
group that generally has problems managing time, concentrating during face-to-face therapy 
sessions, and recall the session content. Additionally, through the technical platform text 
messages can be sent to the patients, in order to remind and encourage them to continue their 
work.  
Despite these advantages, participants in both interventions only completed slightly above 50% 
of the total number of modules, suggesting that strategies designed to increase adherence could 
be an important target area for improvement. This is comparable with the previously published 
ICBT study 58, somewhat lower than a study on ICBT for depression in routine psychiatric care 
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(72%) 112, and also lower than in the face-to-face format in study II where participants on 
average completed 86% of the sessions.  
The overall qualitative evaluations (described more in the manuscripts) showed that the 
majority of the participants were satisfied with the interventions. However, recurring feedback 
pointed out the need for less extensive content (study III) and prolonged treatment time. In 
study III, the average ICBT participant was exposed to six different techniques, each with its 
own educational material and homework, which could have possibly lead to fragmentation. 
Moreover, some participants tried out the new smartphone application which did not work 
optimally due to technical problems, causing additional stress for the participants in ICBT 
Therefore, it seems clear that future studies need to evaluate the effects of more refined 
treatments with reduced content. This approach could increase adherence and ameliorate 
negative experiences of treatment such as feelings of failure and stress, thus enhancing the 
effects and increasing the potential for internet-based interventions as an addition to a 
multimodal treatment for adult ADHD. 
 
Indeed, clinical observations together with participant’s experiences of treatment agree that the 
ambitious and demanding treatment set-up combined with the rapid speed of ICBT could have 
been stressful and overwhelming for a participant group that has difficulties with attention and 
working memory. Most probably, these factors could explain the more frequent interaction 
between therapists and participants in ICBT compared to the control treatment, but given the 
finding therapist contact time was not related to treatment outcome, this would not have altered 
the results. 
Although attempts were made to adapt the combination manual from a face-to-face setting to an 
internet-format, the non-optimal effects of ICBT suggest that further adjustments have to be 
made in future studies in order to enhance the treatment effects and allow ICBT to show its full 
potential in changing ADHD symptoms. While longer treatments have not been associated with 
larger effect sizes in general 113, some promising ways to improve efficacy and feasibility could 
be reducing the amount of written text, adding illustrations and sound files, and identifying and 
removing non-essential treatment modules. An attempt to extract the most useful, 
comprehensible and beneficial treatment components was made in study II, and a similar 
evaluation would consequently be valuable to enhance the internet treatment format in further 
studies. Moreover, evidence from anxiety and depression ICBT trials 114,115 suggests that 
exploring a tailored treatment approach may be the most important line of inquiry. Therefore, 
while there is a clear need to continue to refine ICBT treatment for ADHD, there are a number 
of promising avenues to pursue this mission.  
 
Nevertheless, the specific deficits in this patient population call for a very particular approach in 
treatment development. This begs the question, “Is less more when it comes to delivering 
psychological interventions on internet for adults with ADHD?” Future studies are necessary to 
answer this. However, given the problems with working memory, attention, and the general 
novelty seeking tendencies in individuals with ADHD, it seems likely that a major challenge in 
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creating new psychological interventions for this group will be finding a balance between 
introducing new components in treatment and repeating them in order to maintain their 
motivation.  
 
4.2 Can the use of smartphone applications teach adults with ADHD to improve 
their attention and organization skills?  
 
Compared to the wait-list condition, participants in Living Smart showed larger improvements 
on the primary outcome, measuring attention and organization skills, with a large between 
group size. None of the participants in the wait-list condition reached the criteria for clinical 
significant change, as measured with CGI-I, compared to 33% in the intervention group. 
Furthermore, although decrease in depression and hyperactivity was significant, effects on these 
areas were low, indicating that the intervention had a rather “narrow” effect on inattention and 
organizational skills. This finding is in line with the primary aim of the study, which was to 
reduce problems with inattention and improve organization skills.  
Moreover, the between group effects on inattention were larger compared to study III (d=0.46 
for ICBT) and to Pettersson and colleagues’ study 58 where the between size effects for the 
ICBT self-help group (based on observed means) were d=0.24 compared to a wait-list 
condition. This supports the specificity of the Living Smart intervention. It is notable that these 
effects were retained even after removing the seven participants without ADHD diagnosis in the 
sensitivity analysis. 
 
Given that participants only completed 50% of the course content (on average three out of six 
modules), with Google Calendar as the most used application during this time, the results show 
that advantageous effects can be obtained also with rather limited means. It also indicates the 
potential of smartphone applications as a tool to enhance attention and organization skills for 
adults for ADHD.  
 
There are several obvious advantages of the smartphone as a potential addition in a multimodal 
treatment model for adult ADHD. Today, the smartphone is a highly common and affordable 
device which provides access to free applications 75, 77. This makes it possible for the individual 
to use the phone as a flexible treatment tool without any economic considerations. Furthermore, 
some of the applications, like the calendar system used in the intervention, can be shared with 
another individuals such as parents and spouses, which can facilitate everyday organization and 
planning for adults with ADHD.  
 
However, it is important to be aware of some of the limitations of this study. The response rate 
on full scale ASRS was lower than in study II and III, partly due to the low effects on the 
hyperactivity subscale, suggesting that the intervention only provided limited effects on ADHD 
symptoms in total. Thus, this finding indicates that the selected smartphone applications in 
study I would be more useful for the individuals who primarily have problems with attention 
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and organization skills. However, this was not problematic given that it was the main objective 
of the study. Furthermore, although all participants had pronounced difficulties with inattention 
and organization, not all had a verified diagnosis of ADHD. In addition, they had actively 
sought the intervention and many of the participants were highly educated. These factors may 
limit the generalizability of the results to a clinical and more impaired sample. 
 
Moreover, it is likely that an individual with executive difficulties will, at least initially, need a 
higher degree of guidance when selecting and learning to use smartphone applications. This 
indicates that the applications should be accompanied by clear step-to-step instructions (as in 
the intervention). Thus, the smartphone applications used in this study may not be as effective if 
they are recommended to the individual “as they are” and without any guidance.  The new 
smartphone application developed for study III attempted to integrate useful applications with 
user instructions and rationales, however, due to recurrent technical problems in the 
administration of the new application, adherence information could not be collected and 
analyzed.  
 
In conclusion, the smartphone applications used in study I seem to be promising in improving 
attention and organization skills. However, while the amount of time therapist spent on reading 
and answering messages showed no correlation with primary outcome, non-specific factors 
such as therapist support and attention could have affected the results. Thus, these mechanisms 
need to be further investigated in future studies so that the scope and potential of using the 
smartphone as a treatment aid for adults with ADHD can be clarified. 
 
4.3 Is the new treatment manual for adults with ADHD, combining methods from 
CBT and DBT, feasible and effective in reducing ADHD symptoms in adults?  
 
The primary purpose of developing a new treatment manual with combined methods from CBT 
and DBT was to address the variety and complexity of problems often associated with adult 
ADHD. However, a combined approach could also increase stress and mental “overload” for a 
patient group who has problems with attention and working memory. From the results from 
study II-III, we can conclude that the combined treatment manual was feasible with positive 
effects on both self-reported and observer-rated ADHD symptoms. In study II, participants 
completed 86% of the sessions with high overall ratings of use, comprehension, and perceived 
benefit related to the treatment techniques (described more in the study II article) indicating 
good adherence. In study III, the combined treatment was perceived as more credible than the 
control after five weeks of treatment, and treatment satisfaction was rated as “excellent” in both 
studies 110.  
Moreover, the within group effect sizes on primary outcome were moderate (study III) to large 
(study II), and the latter was comparable to studies on both Safren's and Hesslinger’s manual 
39,50. 
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Thus, the findings indicate that the combined manual could be a promising treatment option for 
adults with ADHD. Positive effects were found also on secondary outcomes measuring 
depression severity, perceived stress and level of functional impairment in both studies. 
  
Furthermore, the results from study II showed a correlation between use and change on primary 
outcome as well as on depression severity and perceived stress, indicating the relevance of the 
treatment components. Comparison of the level of use, comprehension, and benefit of the 
treatment components, also suggested an advantage for organization tools in the combination 
manual. This is possibly because they were introduced first and repeated during the whole 
treatment. Moreover, compared to DBT, these components were also experienced as more 
emotionally neutral and more concrete. Due to these experiences, the DBT components were 
somewhat adjusted in the ICBT manual. Furthermore, a recently published study 113 suggest that 
treatments based on DBT for ADHD including mindfulness and self-regulation skills may be 
associated with lower effect sizes than other treatment types, which thus could be due to the 
more complex and emotional approach of the components in this treatment.  
However, although the results seems promising for the combined treatment, adherence data 
from study III leaves room for improvement and some of the participant’s reports of negative 
treatment experiences (as mentioned previously) indicate that further adjustments should be 
made in the ICBT treatment manual order to increase adherence and acceptability in the future. 
Moreover, there is a possibility that the effects found on ADHD symptoms were mainly caused 
by non-specific factors such as participant expectations, therapist’s contact, a credible rationale, 
or active engagement in any kind of new activity.  
 
4.4 Does the combined treatment manual produce specific or non-specific 
effects?   
 
Since study II was uncontrolled, it is difficult to rule out whether the large effect sizes on 
ADHD symptoms could have been influenced by factors such as the relationship between 
therapists and participants. Moreover, although ICBT was superior to the control treatment on 
some of the secondary outcomes, the overall changes were very similar in both treatments, 
indicating that the effects could be mainly non-specific. However, evidence for the efficacy of 
the control treatment in treating a variety of psychiatric disorders 107,109,116,117, suggests that 
applied relaxation might also be a legitimate treatment option in the treatment of adult ADHD 
that is capable of producing specific effects for this disorder.  
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Indeed, the promising findings for IART could be the result of several advantageous features of 
this treatment compared to ICBT. For example, the content was available not only in text, but 
also through sound files and it was more experientially oriented and less intellectually 
demanding due to the recurring themes throughout treatment. These factors show the potential 
for IART as a treatment option for adults with ADHD with a within group effect size of d=0.93 
at post, which was higher than the within group effect for relaxation training in Safren’s study 
(d=0.68) 39. This could possibly explain the difficulties for ICBT in showing superiority 
regarding change in ADHD symptoms.  
Nonetheless, participants in IART rated the treatment as less credible and satisfactory than 
ICBT, probably because of the narrow and repetitive scope of the treatment. 
 
Another probable explanation for the comparable results between ICBT and IART in study III 
is that the wide array of therapeutic techniques that were presented in the ICBT treatment may 
have been mentally and emotionally overwhelming for the participants when presented in the 
internet-format without the same therapeutic guidance as in study II (described more in detail in 
4.1). Although adjustments had been made to facilitate these components in the ICBT version, it 
is still possible that ICBT did not succeed in reaching its full potential and could have even 
produced non-optimal effects as a result of these issues.  
In conclusion, the question if the combined treatment produce specific effects remains to be 
answered in future trials. Considering that study II was uncontrolled and the combined 
treatment in study III most probably was not implemented optimally, it is likely that the 
combination treatment did not succeed in reaching its full potential in the internet-format.  
 
4.5 What are the long-term effects for the combined treatment?  
 
An analysis of the long-term effects for the combination treatment in studies II-III, showed 
sustained, and slightly increased effects in both studies regarding change on ADHD symptoms 
up to one year after treatment (see Table 4). This suggests that beneficial treatment gains can be 
obtained even after the end of the intervention. The within group effects on ADHD symptoms 
one year after treatment were larger for ICBT in study III (d=0.79) than effects on ADHD 
symptoms six month after treatment (based on observed means; d=0.57) reported in a 
previously published ICBT study 58. Moreover, sustained effects were also found over time for 
ICBT on the secondary outcomes mentioned above, when compared to TAU.  
 
From these results we can conclude the combination manual seems to be promising in reducing 
ADHD symptoms over time, but this finding begs the question of why this might be the case. 
One possible explanation could be that participants who initially benefited from treatment 
continue to work with and remind themselves of the principles of treatment 118 which could lead 
to maintained treatment effects over a longer period of time. Additionally, a clear advantage of 
the internet-based programs is the possibility to access treatment even after the treatment has 
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ended which enables continued work through repeating the text material and rehearsing 
exercises. However, due to the fact that the long-term effects were uncontrolled in both studies 
(i.e. the last controlled comparison in study III was at three month follow-up assessments), 
future trials are needed to support the long-term effects for the combination treatment. 
 
4.6 LIMITATIONS 
 
General limitations of study I-III are described in the following section. 
Can the results be generalized to the entire ADHD population in psychiatric healthcare? All 
participants included in study II-III were assessed and diagnosed in specialized ADHD units, 
and in study II the participants were also recruited directly from such a unit, indicating high 
generalizability to the ADHD population in psychiatric healthcare. However, in the internet-
based studies, the participants were more often women, self-referred, more highly educated and 
with lower comorbidity rates compared to those in study II. Moreover, a difference between the 
participants in study II and the internet-based interventions was that the latter more actively 
sought treatment without the involvement from caregivers, possibly decreasing generalizability 
to a clinical and more impaired sample. This could also indicate that internet-based 
interventions attract more highly educated people because of the text and self-help based 
format.  
 
Another limitation is that 12% of the participants in study I did not prove to have an ADHD 
diagnosis, and for some other participants, diagnosis could not be confirmed. Nevertheless, 88% 
of the participants had either confirmed or highly probable ADHD, and the sub-analysis where 
those without ADHD diagnosis were removed did not change the results.  
However, it is reasonable to conclude that the results from study I primarily are generalizable to 
individuals with ADHD who primarily have significant problems with organization and 
attention.  
 
Using ASRS v.1.1 as the primary outcome. In all studies, the use of participant-rated ASRS as 
primary outcome could have influenced the results, due to possible expectancy effects. To 
control for these effects, blinded observer ratings had been preferable as the primary outcome.  
However, the outcome from ASRS was actually verified in study II-III, where observer rated 
ADHD Rating scale (blinded in study III) showed highly similar results.  
Furthermore, ASRS has primarily been used to measure symptom change in pharmacological 
studies 119 which could imply that ASRS is not as effective in measuring function improvement 
and change which often is the target in psychotherapy trials. To date, except for Adult ADHD 
Quality of Life Questionnaire 120 which only partially measures impairment in function, there is 
no function scale developed for this target group which had been preferable to use in study I-III.  
However, the general functional disability measure (SDS) showed moderate to large within 
group effect sizes in all three studies, indicating that the participants improved in symptoms as 
well as their functioning, after the interventions. 
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Engagement in other medical and/or therapeutic interventions. In study I and III, some of the 
participants reported that they had been engaged in other medical and/or therapeutic 
interventions during their treatments. Unfortunately, we were not able to control these 
engagements, which could have influenced the results. However, no differences in this respect 
were found between the groups in study I and III. 
Statistical power. In study III, power analysis was calculated on 140 participants, but the study 
was discontinued after recruiting 104 participants due to shortage of time and resources. Thus, 
the question is if we had enough power to find an effect between the treatment groups. 
However, preliminary analysis and clinical observations indicated that adding 36 individuals 
(13 in each group) most probably would not have altered the results.  
 
4.7 FUTURE DIRECTIONS 
 
Suggestions for future research are presented below based on the questions that have emerged 
from study I-III. 
 Does the combined treatment produce specific effects?  
As described in the Discussion (4.4), the specific effects of the combination treatment should 
be further evaluated in future controlled trials. 
 Do participants without ADHD medication benefit from the combination treatment? In study 
II, a sub-analysis revealed no differences between medicated (n=13) and non-medicated 
(n=5) participants, indicating that the combination treatment can also be effective for non-
medicated individuals. However, this result must be interpreted with some caution due to the 
low statistical power. Larger studies should examine the effect of CBT and the combination 
treatment, especially on adults with ADHD who cannot take medication for any number of 
reasons.  
 Could future versions of the ICBT treatment benefit from the treatment set-up and content of 
IART? One hypothesis that emerged from study III is that a more repetitive, “narrow” and 
experientially oriented content could be beneficial for adults for ADHD, due to their 
problems with i.e. attention and working memory. Another suggestion is to include 
components from applied relaxation training in the combination manual because of the 
effects seen in study III. This could potentially be used as an alternative to mindfulness 
exercises for participants who prefer this method. However, adding new components to the 
combined treatment must be handled with some caution due to the risk of overwhelming the 
patients, which is an important lesson learned from study III. Furthermore, a future 
suggestion is also to make the technical platform responsive to mobile phones to increase 
adherence. 
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 Would larger effects be achieved with a tailored internet-treatment based on the 
combination manual? The results from study III indicate that reducing the number of 
techniques presented in the ICBT treatment could be beneficial for the participants. 
However, the techniques that would be beneficial to use still need to be determined. Further 
studies should focus on evaluating the use, understanding, and benefit of the treatment 
modules in order to extract the most effective treatment components, similar to study II. 
 Who benefits most from treatment, and which mechanisms are responsible for the change of 
ADHD symptoms? Clinical observations indicate that participants with predominantly 
inattentive symptoms, had more adherence difficulties during treatment, and that participants 
with comorbid, high functioning ASD did well. However, there is still so much more to 
understand about who responds to treatment and why. Thus, potential predictors and 
mediators should be explored to increase knowledge about mechanisms of change. 
 How important is the therapeutic guidance in ICBT? In study III, there were major 
differences between degree of therapist time spent in the treatments between ICBT and 
IART. However, these differences did not alter the highly comparable results for ICBT and 
IART in outcome. Clearly, this can be explained by several factors mentioned in the 
discussion section, but it would be interesting to examine if less therapist time spent would 
alter the results for ICBT. If future ICBT treatments produce effective results despite less 
therapist effort, the cost-effectiveness would increase which would be beneficial for the 
individual and society.  
 Should the group-treatment based on the combination manual or ICBT for adults with 
ADHD be implemented within regular psychiatric health care? All participants in study II 
were recruited directly for specialized ADHD units, thus, this indicates that the promising 
results found in study II are generalizable to the ADHD population in psychiatric healthcare. 
However, if we think of the group treatment as a replacement to the standard Safren 57 or 
Hesslinger 103 treatments which are usually provided in psychiatric healthcare, we need to 
evaluate it in non-inferiority trials before implementation. Furthermore, if future trials further 
strengthen the evidence for ICBT treatment, it could be offered to the patients as a 
supplementary to other therapeutic interventions in psychiatric health-care (and not as a 
replacement, due to the limitations in generalizability mentioned before).  
 Can the interventions evaluated in studies I-III all be parts of a multimodal, stepped-care 
treatment approach for adults with ADHD? If future studies verify our findings, 
interventions in studies I and III could be presented to interested individuals directly after 
diagnosis, followed by the group treatment evaluated in study II for individuals who are still 
in need of more support and therapy after these interventions. 
This stepped-care approach could thus be effective in saving therapist resources in 
psychiatric health care, and lead to a higher accessibility and availability of evidence-based 
psychological treatment to a participant group that needs other interventions than just 
medication. 
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5  CONCLUSIONS 
 
The primary aims of this thesis were to develop and evaluate the efficacy of new psychological 
interventions for adult ADHD, addressing a variety of related problems, with the intention to 
make these interventions accessible and available through the internet.  
The following conclusions can be drawn from studies I-III: 
 Internet-based interventions seem to be a feasible way to treat adults with ADHD. In general, 
treatment satisfaction and adherence were good, but the findings indicate that there must be 
further adjustments in content in order to enhance adherence and effects. 
 Smartphone applications and online tools can help adults with ADHD and individuals with 
pronounced problems with inattention and organization to improve these skills. 
 The new combination manual based on interventions from CBT and DBT seems to be 
feasible and effective in the treatment of adult ADHD when provided in a group setting and 
through the internet. However, the effects can also be explained by non-specific factors and 
therefore, future controlled trials are needed to evaluate the specific effects of the combined 
treatment. 
 The reductions of ADHD symptoms were maintained and slightly increased up to one year 
after treatment, suggesting lasting treatment gains. 
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